Global Targeted Liposomes Drug Delivery Market by Application (Cancer Therapy, Photodynamic Therapy, Fungal Diseases, Pain Technology, Viral Vaccines), by Product (Liposomal Paclitaxel, Liposomal Doxorubicin, Liposomal Amphotericin B), by Technology (DepoFoam Liposome Technology, Stealth Liposome Technology, Non-PEGylated Liposome Technology) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Targeted Liposomes Drug Delivery Market research report which is segmented by Application (Cancer Therapy, Photodynamic Therapy, Fungal Diseases, Pain Technology, Viral Vaccines), by Product (Liposomal Paclitaxel, Liposomal Doxorubicin, Liposomal Amphotericin B), by Technology (DepoFoam Liposome Technology, Stealth Liposome Technology, Non-PEGylated Liposome Technology), By Players/Companies Ipsen Pharma, Celsion Corporation, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Gilead Sciences Inc., Spectrum Pharmaceuticals Inc., Johnson and Johnson, Luye Pharma Group, Novartis AG, Pacira BioSciences Inc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Targeted Liposomes Drug Delivery Market Research Report |
| By Application | Cancer Therapy, Photodynamic Therapy, Fungal Diseases, Pain Technology, Viral Vaccines |
| By Product | Liposomal Paclitaxel, Liposomal Doxorubicin, Liposomal Amphotericin B |
| By Technology | DepoFoam Liposome Technology, Stealth Liposome Technology, Non-PEGylated Liposome Technology |
| By Companies | Ipsen Pharma, Celsion Corporation, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Gilead Sciences Inc., Spectrum Pharmaceuticals Inc., Johnson and Johnson, Luye Pharma Group, Novartis AG, Pacira BioSciences Inc. |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 219 |
| Number of Tables & Figures | 154 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Targeted Liposomes Drug Delivery Market Report Segments:
The market is segmented by Application (Cancer Therapy, Photodynamic Therapy, Fungal Diseases, Pain Technology, Viral Vaccines), by Product (Liposomal Paclitaxel, Liposomal Doxorubicin, Liposomal Amphotericin B), by Technology (DepoFoam Liposome Technology, Stealth Liposome Technology, Non-PEGylated Liposome Technology).
Some of the companies that are profiled in this report are:
- Ipsen Pharma
- Celsion Corporation
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Gilead Sciences Inc.
- Spectrum Pharmaceuticals Inc.
- Johnson and Johnson
- Luye Pharma Group
- Novartis AG
- Pacira BioSciences Inc.
Targeted Liposomes Drug Delivery Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Targeted Liposomes Drug Delivery Market
Overview of the regional outlook of the Targeted Liposomes Drug Delivery Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Targeted Liposomes Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Targeted Liposomes Drug Delivery Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Cancer Therapy
2. Photodynamic Therapy
3. Fungal Diseases
4. Pain Technology
5. Viral Vaccines
7. By Product:1. Liposomal Paclitaxel
2. Liposomal Doxorubicin
3. Liposomal Amphotericin B
8. By Technology:1. DepoFoam Liposome Technology
2. Stealth Liposome Technology
3. Non-PEGylated Liposome Technology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted Liposomes Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Targeted Liposomes Drug Delivery Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Targeted Liposomes Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Targeted Liposomes Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Targeted Liposomes Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Targeted Liposomes Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Targeted Liposomes Drug Delivery Market Size & Forecast, 2018-2028
4.5.1 Targeted Liposomes Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Targeted Liposomes Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Targeted Liposomes Drug Delivery Market Size Forecast by Application
5.2.1 Cancer Therapy
5.2.2 Photodynamic Therapy
5.2.3 Fungal Diseases
5.2.4 Pain Technology
5.2.5 Viral Vaccines
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Targeted Liposomes Drug Delivery Market Size Forecast by Product
6.2.1 Liposomal Paclitaxel
6.2.2 Liposomal Doxorubicin
6.2.3 Liposomal Amphotericin B
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Technology
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Technology
7.1.2 Basis Point Share (BPS) Analysis by Technology
7.1.3 Absolute $ Opportunity Assessment by Technology
7.2 Targeted Liposomes Drug Delivery Market Size Forecast by Technology
7.2.1 DepoFoam Liposome Technology
7.2.2 Stealth Liposome Technology
7.2.3 Non-PEGylated Liposome Technology
7.3 Market Attractiveness Analysis by Technology
Chapter 8 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Targeted Liposomes Drug Delivery Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Targeted Liposomes Drug Delivery Analysis and Forecast
10.1 Introduction
10.2 North America Targeted Liposomes Drug Delivery Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Targeted Liposomes Drug Delivery Market Size Forecast by Application
10.6.1 Cancer Therapy
10.6.2 Photodynamic Therapy
10.6.3 Fungal Diseases
10.6.4 Pain Technology
10.6.5 Viral Vaccines
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 North America Targeted Liposomes Drug Delivery Market Size Forecast by Product
10.10.1 Liposomal Paclitaxel
10.10.2 Liposomal Doxorubicin
10.10.3 Liposomal Amphotericin B
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
10.14 North America Targeted Liposomes Drug Delivery Market Size Forecast by Technology
10.14.1 DepoFoam Liposome Technology
10.14.2 Stealth Liposome Technology
10.14.3 Non-PEGylated Liposome Technology
10.15 Basis Point Share (BPS) Analysis by Technology
10.16 Absolute $ Opportunity Assessment by Technology
10.17 Market Attractiveness Analysis by Technology
Chapter 11 Europe Targeted Liposomes Drug Delivery Analysis and Forecast
11.1 Introduction
11.2 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Application
11.6.1 Cancer Therapy
11.6.2 Photodynamic Therapy
11.6.3 Fungal Diseases
11.6.4 Pain Technology
11.6.5 Viral Vaccines
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Product
11.10.1 Liposomal Paclitaxel
11.10.2 Liposomal Doxorubicin
11.10.3 Liposomal Amphotericin B
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
11.14 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Technology
11.14.1 DepoFoam Liposome Technology
11.14.2 Stealth Liposome Technology
11.14.3 Non-PEGylated Liposome Technology
11.15 Basis Point Share (BPS) Analysis by Technology
11.16 Absolute $ Opportunity Assessment by Technology
11.17 Market Attractiveness Analysis by Technology
Chapter 12 Asia Pacific Targeted Liposomes Drug Delivery Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Application
12.6.1 Cancer Therapy
12.6.2 Photodynamic Therapy
12.6.3 Fungal Diseases
12.6.4 Pain Technology
12.6.5 Viral Vaccines
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Product
12.10.1 Liposomal Paclitaxel
12.10.2 Liposomal Doxorubicin
12.10.3 Liposomal Amphotericin B
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
12.14 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Technology
12.14.1 DepoFoam Liposome Technology
12.14.2 Stealth Liposome Technology
12.14.3 Non-PEGylated Liposome Technology
12.15 Basis Point Share (BPS) Analysis by Technology
12.16 Absolute $ Opportunity Assessment by Technology
12.17 Market Attractiveness Analysis by Technology
Chapter 13 Latin America Targeted Liposomes Drug Delivery Analysis and Forecast
13.1 Introduction
13.2 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Application
13.6.1 Cancer Therapy
13.6.2 Photodynamic Therapy
13.6.3 Fungal Diseases
13.6.4 Pain Technology
13.6.5 Viral Vaccines
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Product
13.10.1 Liposomal Paclitaxel
13.10.2 Liposomal Doxorubicin
13.10.3 Liposomal Amphotericin B
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
13.14 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Technology
13.14.1 DepoFoam Liposome Technology
13.14.2 Stealth Liposome Technology
13.14.3 Non-PEGylated Liposome Technology
13.15 Basis Point Share (BPS) Analysis by Technology
13.16 Absolute $ Opportunity Assessment by Technology
13.17 Market Attractiveness Analysis by Technology
Chapter 14 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Application
14.6.1 Cancer Therapy
14.6.2 Photodynamic Therapy
14.6.3 Fungal Diseases
14.6.4 Pain Technology
14.6.5 Viral Vaccines
14.7 Basis Point Share (BPS) Analysis by Application
14.8 Absolute $ Opportunity Assessment by Application
14.9 Market Attractiveness Analysis by Application
14.10 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Product
14.10.1 Liposomal Paclitaxel
14.10.2 Liposomal Doxorubicin
14.10.3 Liposomal Amphotericin B
14.11 Basis Point Share (BPS) Analysis by Product
14.12 Absolute $ Opportunity Assessment by Product
14.13 Market Attractiveness Analysis by Product
14.14 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Technology
14.14.1 DepoFoam Liposome Technology
14.14.2 Stealth Liposome Technology
14.14.3 Non-PEGylated Liposome Technology
14.15 Basis Point Share (BPS) Analysis by Technology
14.16 Absolute $ Opportunity Assessment by Technology
14.17 Market Attractiveness Analysis by Technology
Chapter 15 Competition Landscape
15.1 Targeted Liposomes Drug Delivery Market: Competitive Dashboard
15.2 Global Targeted Liposomes Drug Delivery Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Ipsen Pharma
15.3.2 Celsion Corporation
15.3.3 Takeda Pharmaceutical Company Limited
15.3.4 Astellas Pharma Inc.
15.3.5 Gilead Sciences Inc.
15.3.6 Spectrum Pharmaceuticals Inc.
15.3.7 Johnson and Johnson
15.3.8 Luye Pharma Group
15.3.9 Novartis AG
15.3.10 Pacira BioSciences Inc.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Targeted Liposomes Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Targeted Liposomes Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Targeted Liposomes Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Targeted Liposomes Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Targeted Liposomes Drug Delivery Market Size & Forecast, 2018-2028
4.5.1 Targeted Liposomes Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Targeted Liposomes Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Targeted Liposomes Drug Delivery Market Size Forecast by Application
5.2.1 Cancer Therapy
5.2.2 Photodynamic Therapy
5.2.3 Fungal Diseases
5.2.4 Pain Technology
5.2.5 Viral Vaccines
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Targeted Liposomes Drug Delivery Market Size Forecast by Product
6.2.1 Liposomal Paclitaxel
6.2.2 Liposomal Doxorubicin
6.2.3 Liposomal Amphotericin B
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Technology
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Technology
7.1.2 Basis Point Share (BPS) Analysis by Technology
7.1.3 Absolute $ Opportunity Assessment by Technology
7.2 Targeted Liposomes Drug Delivery Market Size Forecast by Technology
7.2.1 DepoFoam Liposome Technology
7.2.2 Stealth Liposome Technology
7.2.3 Non-PEGylated Liposome Technology
7.3 Market Attractiveness Analysis by Technology
Chapter 8 Global Targeted Liposomes Drug Delivery Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Targeted Liposomes Drug Delivery Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Targeted Liposomes Drug Delivery Analysis and Forecast
10.1 Introduction
10.2 North America Targeted Liposomes Drug Delivery Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Targeted Liposomes Drug Delivery Market Size Forecast by Application
10.6.1 Cancer Therapy
10.6.2 Photodynamic Therapy
10.6.3 Fungal Diseases
10.6.4 Pain Technology
10.6.5 Viral Vaccines
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 North America Targeted Liposomes Drug Delivery Market Size Forecast by Product
10.10.1 Liposomal Paclitaxel
10.10.2 Liposomal Doxorubicin
10.10.3 Liposomal Amphotericin B
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
10.14 North America Targeted Liposomes Drug Delivery Market Size Forecast by Technology
10.14.1 DepoFoam Liposome Technology
10.14.2 Stealth Liposome Technology
10.14.3 Non-PEGylated Liposome Technology
10.15 Basis Point Share (BPS) Analysis by Technology
10.16 Absolute $ Opportunity Assessment by Technology
10.17 Market Attractiveness Analysis by Technology
Chapter 11 Europe Targeted Liposomes Drug Delivery Analysis and Forecast
11.1 Introduction
11.2 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Application
11.6.1 Cancer Therapy
11.6.2 Photodynamic Therapy
11.6.3 Fungal Diseases
11.6.4 Pain Technology
11.6.5 Viral Vaccines
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Product
11.10.1 Liposomal Paclitaxel
11.10.2 Liposomal Doxorubicin
11.10.3 Liposomal Amphotericin B
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
11.14 Europe Targeted Liposomes Drug Delivery Market Size Forecast by Technology
11.14.1 DepoFoam Liposome Technology
11.14.2 Stealth Liposome Technology
11.14.3 Non-PEGylated Liposome Technology
11.15 Basis Point Share (BPS) Analysis by Technology
11.16 Absolute $ Opportunity Assessment by Technology
11.17 Market Attractiveness Analysis by Technology
Chapter 12 Asia Pacific Targeted Liposomes Drug Delivery Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Application
12.6.1 Cancer Therapy
12.6.2 Photodynamic Therapy
12.6.3 Fungal Diseases
12.6.4 Pain Technology
12.6.5 Viral Vaccines
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Product
12.10.1 Liposomal Paclitaxel
12.10.2 Liposomal Doxorubicin
12.10.3 Liposomal Amphotericin B
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
12.14 Asia Pacific Targeted Liposomes Drug Delivery Market Size Forecast by Technology
12.14.1 DepoFoam Liposome Technology
12.14.2 Stealth Liposome Technology
12.14.3 Non-PEGylated Liposome Technology
12.15 Basis Point Share (BPS) Analysis by Technology
12.16 Absolute $ Opportunity Assessment by Technology
12.17 Market Attractiveness Analysis by Technology
Chapter 13 Latin America Targeted Liposomes Drug Delivery Analysis and Forecast
13.1 Introduction
13.2 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Application
13.6.1 Cancer Therapy
13.6.2 Photodynamic Therapy
13.6.3 Fungal Diseases
13.6.4 Pain Technology
13.6.5 Viral Vaccines
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Product
13.10.1 Liposomal Paclitaxel
13.10.2 Liposomal Doxorubicin
13.10.3 Liposomal Amphotericin B
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
13.14 Latin America Targeted Liposomes Drug Delivery Market Size Forecast by Technology
13.14.1 DepoFoam Liposome Technology
13.14.2 Stealth Liposome Technology
13.14.3 Non-PEGylated Liposome Technology
13.15 Basis Point Share (BPS) Analysis by Technology
13.16 Absolute $ Opportunity Assessment by Technology
13.17 Market Attractiveness Analysis by Technology
Chapter 14 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Application
14.6.1 Cancer Therapy
14.6.2 Photodynamic Therapy
14.6.3 Fungal Diseases
14.6.4 Pain Technology
14.6.5 Viral Vaccines
14.7 Basis Point Share (BPS) Analysis by Application
14.8 Absolute $ Opportunity Assessment by Application
14.9 Market Attractiveness Analysis by Application
14.10 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Product
14.10.1 Liposomal Paclitaxel
14.10.2 Liposomal Doxorubicin
14.10.3 Liposomal Amphotericin B
14.11 Basis Point Share (BPS) Analysis by Product
14.12 Absolute $ Opportunity Assessment by Product
14.13 Market Attractiveness Analysis by Product
14.14 Middle East & Africa (MEA) Targeted Liposomes Drug Delivery Market Size Forecast by Technology
14.14.1 DepoFoam Liposome Technology
14.14.2 Stealth Liposome Technology
14.14.3 Non-PEGylated Liposome Technology
14.15 Basis Point Share (BPS) Analysis by Technology
14.16 Absolute $ Opportunity Assessment by Technology
14.17 Market Attractiveness Analysis by Technology
Chapter 15 Competition Landscape
15.1 Targeted Liposomes Drug Delivery Market: Competitive Dashboard
15.2 Global Targeted Liposomes Drug Delivery Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Ipsen Pharma
15.3.2 Celsion Corporation
15.3.3 Takeda Pharmaceutical Company Limited
15.3.4 Astellas Pharma Inc.
15.3.5 Gilead Sciences Inc.
15.3.6 Spectrum Pharmaceuticals Inc.
15.3.7 Johnson and Johnson
15.3.8 Luye Pharma Group
15.3.9 Novartis AG
15.3.10 Pacira BioSciences Inc.
Segments Covered in the Report
The global Targeted Liposomes Drug Delivery market has been segmented based on
By Application
The global Targeted Liposomes Drug Delivery market has been segmented based on
By Application
- Cancer Therapy
- Photodynamic Therapy
- Fungal Diseases
- Pain Technology
- Viral Vaccines
- Liposomal Paclitaxel
- Liposomal Doxorubicin
- Liposomal Amphotericin B
- DepoFoam Liposome Technology
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Ipsen Pharma
- Celsion Corporation
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Gilead Sciences Inc.
- Spectrum Pharmaceuticals Inc.
- Johnson and Johnson
- Luye Pharma Group
- Novartis AG
- Pacira BioSciences Inc.
Our Clients
Related Reports
Some other reports from this category!
